Listed

BioXcel Therapeutics, Inc.

BTAIQOTCCIK 1720893HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$182.0k, Q2 FY2026
Operating income−$10.2m, Q2 FY2026
Net income−$14.7m, Q2 FY2026
BioXcel Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m0.3Revenue, Q3 FY2023, three months to 2023-09-30$341.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figure0.4Revenue, Q4 FY2023, three months to 2023-12-31$376.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-28, accession 0001558370-25-003985. Derived: 12-month figure less the 9-month figure.Report this figure0.6Revenue, Q1 FY2024, three months to 2024-03-31$582.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure1.1Revenue, Q2 FY2024, three months to 2024-06-30$1.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure0.2Revenue, Q3 FY2024, three months to 2024-09-30$214.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure0.4Revenue, Q4 FY2024, three months to 2024-12-31$366.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure0.2Revenue, Q1 FY2025, three months to 2025-03-31$168.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure0.1Revenue, Q2 FY2025, three months to 2025-06-30$120.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure0.1Revenue, Q3 FY2025, three months to 2025-09-30$98.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure0.3Revenue, Q4 FY2025, three months to 2025-12-31$256.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure0.2Revenue, Q1 FY2026, three months to 2026-03-31$206.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure0.2Revenue, Q2 FY2026, three months to 2026-06-30$182.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Cost of revenue$m0.5Cost of revenue, Q3 FY2023, three months to 2023-09-30$512.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figure0.7Cost of revenue, Q4 FY2023, three months to 2023-12-31$714.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-28, accession 0001558370-25-003985. Derived: 12-month figure less the 9-month figure.Report this figure0.1Cost of revenue, Q1 FY2024, three months to 2024-03-31$80.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure0.1Cost of revenue, Q2 FY2024, three months to 2024-06-30$62.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure1.2Cost of revenue, Q3 FY2024, three months to 2024-09-30$1.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure0.8Cost of revenue, Q4 FY2024, three months to 2024-12-31$832.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$14.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure0.1Cost of revenue, Q2 FY2025, three months to 2025-06-30$107.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure0.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$11.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure0.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$32.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure0.3Cost of revenue, Q1 FY2026, three months to 2026-03-31$283.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure0.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$22.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Research and development$m19.6Research and development, Q3 FY2023, three months to 2023-09-30$19.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figure9.9Research and development, Q4 FY2023, three months to 2023-12-31$9.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-28, accession 0001558370-25-003985. Derived: 12-month figure less the 9-month figure.Report this figure11.4Research and development, Q1 FY2024, three months to 2024-03-31$11.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure8.0Research and development, Q2 FY2024, three months to 2024-06-30$8.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure5.1Research and development, Q3 FY2024, three months to 2024-09-30$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure5.9Research and development, Q4 FY2024, three months to 2024-12-31$5.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure4.6Research and development, Q1 FY2025, three months to 2025-03-31$4.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure10.3Research and development, Q2 FY2025, three months to 2025-06-30$10.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure8.7Research and development, Q3 FY2025, three months to 2025-09-30$8.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure6.7Research and development, Q4 FY2025, three months to 2025-12-31$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure3.0Research and development, Q1 FY2026, three months to 2026-03-31$3.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure3.2Research and development, Q2 FY2026, three months to 2026-06-30$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Selling, general and administrative$m24.3Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$24.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figure9.6Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$9.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-28, accession 0001558370-25-003985. Derived: 12-month figure less the 9-month figure.Report this figure13.3Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$13.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure9.5Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$9.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure7.7Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$7.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure4.1Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$4.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure5.7Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$5.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure5.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$5.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure5.4Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$5.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure3.8Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$3.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure7.2Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$7.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure7.2Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$7.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Operating income$m(48.3)Operating income, Q3 FY2023, three months to 2023-09-30−$48.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figure(19.9)Operating income, Q4 FY2023, three months to 2023-12-31−$19.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-28, accession 0001558370-25-003985. Derived: 12-month figure less the 9-month figure.Report this figure(24.2)Operating income, Q1 FY2024, three months to 2024-03-31−$24.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure(17.3)Operating income, Q2 FY2024, three months to 2024-06-30−$17.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure(15.3)Operating income, Q3 FY2024, three months to 2024-09-30−$15.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure(10.5)Operating income, Q4 FY2024, three months to 2024-12-31−$10.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure(10.1)Operating income, Q1 FY2025, three months to 2025-03-31−$10.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure(15.9)Operating income, Q2 FY2025, three months to 2025-06-30−$15.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure(14.2)Operating income, Q3 FY2025, three months to 2025-09-30−$14.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure(10.3)Operating income, Q4 FY2025, three months to 2025-12-31−$10.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure(10.2)Operating income, Q1 FY2026, three months to 2026-03-31−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure(10.2)Operating income, Q2 FY2026, three months to 2026-06-30−$10.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Interest expense$m3.3Interest expense, Q3 FY2023, three months to 2023-09-30$3.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0001558370-23-018917.Report this figure3.4Interest expense, Q4 FY2023, three months to 2023-12-31$3.4m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-22, accession 0001558370-24-003784. Derived: 12-month figure less the 9-month figure.Report this figure3.6Interest expense, Q1 FY2024, three months to 2024-03-31$3.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0001558370-24-007481.Report this figure3.7Interest expense, Q2 FY2024, three months to 2024-06-30$3.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure3.8Interest expense, Q3 FY2024, three months to 2024-09-30$3.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure4.0Interest expense, Q4 FY2024, three months to 2024-12-31$4.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure4.0Interest expense, Q1 FY2025, three months to 2025-03-31$4.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure4.2Interest expense, Q2 FY2025, three months to 2025-06-30$4.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure4.4Interest expense, Q3 FY2025, three months to 2025-09-30$4.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure4.4Interest expense, Q4 FY2025, three months to 2025-12-31$4.4m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure4.2Interest expense, Q1 FY2026, three months to 2026-03-31$4.2m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure4.3Interest expense, Q2 FY2026, three months to 2026-06-30$4.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Net income$m(50.5)Net income, Q3 FY2023, three months to 2023-09-30−$50.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figure(22.3)Net income, Q4 FY2023, three months to 2023-12-31−$22.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-28, accession 0001558370-25-003985. Derived: 12-month figure less the 9-month figure.Report this figure(26.8)Net income, Q1 FY2024, three months to 2024-03-31−$26.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure(8.3)Net income, Q2 FY2024, three months to 2024-06-30−$8.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure(13.7)Net income, Q3 FY2024, three months to 2024-09-30−$13.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure(10.9)Net income, Q4 FY2024, three months to 2024-12-31−$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure(7.3)Net income, Q1 FY2025, three months to 2025-03-31−$7.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure(19.2)Net income, Q2 FY2025, three months to 2025-06-30−$19.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure(30.9)Net income, Q3 FY2025, three months to 2025-09-30−$30.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure(12.5)Net income, Q4 FY2025, three months to 2025-12-31−$12.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure(12.7)Net income, Q1 FY2026, three months to 2026-03-31−$12.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure(14.7)Net income, Q2 FY2026, three months to 2026-06-30−$14.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Diluted EPS$ per share(1.72)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$1.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figurenot reported(13.89)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$13.89 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure(3.30)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$3.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure(5.15)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$5.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figurenot reported(1.50)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure(2.45)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$2.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure(2.18)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$2.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figurenot reported(0.54)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure(0.49)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Basic EPS$ per share(1.72)Basic EPS, Q3 FY2023, three months to 2023-09-30−$1.72 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figurenot reported(13.89)Basic EPS, Q1 FY2024, three months to 2024-03-31−$13.89 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure(3.30)Basic EPS, Q2 FY2024, three months to 2024-06-30−$3.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure(5.15)Basic EPS, Q3 FY2024, three months to 2024-09-30−$5.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figurenot reported(1.50)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure(2.45)Basic EPS, Q2 FY2025, three months to 2025-06-30−$2.45 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure(2.18)Basic EPS, Q3 FY2025, three months to 2025-09-30−$2.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figurenot reported(0.54)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure(0.49)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure

Balance sheet

Cash and equivalents$12.8m, Q2 FY2026
Long-term debt$0, Q2 FY2026
Shareholders' equity−$115.5m, Q2 FY2026
BioXcel Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m90.0Cash and equivalents, Q3 FY2023, at 2023-09-30$90.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001558370-23-018917.Report this figure65.2Cash and equivalents, FY2023, at 2023-12-31$65.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-28, accession 0001558370-25-003985.Report this figure74.1Cash and equivalents, Q1 FY2024, at 2024-03-31$74.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001558370-24-007481.Report this figure56.3Cash and equivalents, Q2 FY2024, at 2024-06-30$56.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001558370-24-010967.Report this figure40.4Cash and equivalents, Q3 FY2024, at 2024-09-30$40.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure29.9Cash and equivalents, FY2024, at 2024-12-31$29.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-27, accession 0001104659-26-036214.Report this figure31.0Cash and equivalents, Q1 FY2025, at 2025-03-31$31.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure17.4Cash and equivalents, Q2 FY2025, at 2025-06-30$17.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure36.2Cash and equivalents, Q3 FY2025, at 2025-09-30$36.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure28.4Cash and equivalents, FY2025, at 2025-12-31$28.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure17.2Cash and equivalents, Q1 FY2026, at 2026-03-31$17.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure12.8Cash and equivalents, Q2 FY2026, at 2026-06-30$12.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Current assets$m98.7Current assets, Q3 FY2023, at 2023-09-30$98.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-018917.Report this figure72.1Current assets, FY2023, at 2023-12-31$72.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-28, accession 0001558370-25-003985.Report this figure80.9Current assets, Q1 FY2024, at 2024-03-31$80.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001558370-24-007481.Report this figure64.2Current assets, Q2 FY2024, at 2024-06-30$64.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-010967.Report this figure47.8Current assets, Q3 FY2024, at 2024-09-30$47.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figure37.4Current assets, FY2024, at 2024-12-31$37.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-27, accession 0001104659-26-036214.Report this figure37.8Current assets, Q1 FY2025, at 2025-03-31$37.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure25.2Current assets, Q2 FY2025, at 2025-06-30$25.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure44.4Current assets, Q3 FY2025, at 2025-09-30$44.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure44.7Current assets, FY2025, at 2025-12-31$44.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure33.9Current assets, Q1 FY2026, at 2026-03-31$33.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure28.7Current assets, Q2 FY2026, at 2026-06-30$28.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Total assets$m100Total assets, Q3 FY2023, at 2023-09-30$100.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001558370-23-018917.Report this figure73.7Total assets, FY2023, at 2023-12-31$73.7m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-28, accession 0001558370-25-003985.Report this figure82.3Total assets, Q1 FY2024, at 2024-03-31$82.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001558370-24-007481.Report this figure65.4Total assets, Q2 FY2024, at 2024-06-30$65.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001558370-24-010967.Report this figure48.9Total assets, Q3 FY2024, at 2024-09-30$48.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figure38.3Total assets, FY2024, at 2024-12-31$38.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-27, accession 0001104659-26-036214.Report this figure38.6Total assets, Q1 FY2025, at 2025-03-31$38.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure25.8Total assets, Q2 FY2025, at 2025-06-30$25.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure44.8Total assets, Q3 FY2025, at 2025-09-30$44.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure44.9Total assets, FY2025, at 2025-12-31$44.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure34.0Total assets, Q1 FY2026, at 2026-03-31$34.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure28.8Total assets, Q2 FY2026, at 2026-06-30$28.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Current liabilities$m39.4Current liabilities, Q3 FY2023, at 2023-09-30$39.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001558370-23-018917.Report this figure27.3Current liabilities, FY2023, at 2023-12-31$27.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-28, accession 0001558370-25-003985.Report this figure31.5Current liabilities, Q1 FY2024, at 2024-03-31$31.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001558370-24-007481.Report this figure27.3Current liabilities, Q2 FY2024, at 2024-06-30$27.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001558370-24-010967.Report this figure25.6Current liabilities, Q3 FY2024, at 2024-09-30$25.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figure22.2Current liabilities, FY2024, at 2024-12-31$22.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-27, accession 0001104659-26-036214.Report this figure25.5Current liabilities, Q1 FY2025, at 2025-03-31$25.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure33.4Current liabilities, Q2 FY2025, at 2025-06-30$33.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure37.8Current liabilities, Q3 FY2025, at 2025-09-30$37.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure53.9Current liabilities, FY2025, at 2025-12-31$53.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure55.0Current liabilities, Q1 FY2026, at 2026-03-31$55.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure137Current liabilities, Q2 FY2026, at 2026-06-30$137.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Total liabilities$m141Total liabilities, Q3 FY2023, at 2023-09-30$141.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001558370-23-018917.Report this figure130Total liabilities, FY2023, at 2023-12-31$130.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-28, accession 0001558370-25-003985.Report this figure155Total liabilities, Q1 FY2024, at 2024-03-31$154.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001558370-24-007481.Report this figure140Total liabilities, Q2 FY2024, at 2024-06-30$139.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001558370-24-010967.Report this figure135Total liabilities, Q3 FY2024, at 2024-09-30$134.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figure131Total liabilities, FY2024, at 2024-12-31$131.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-27, accession 0001104659-26-036214.Report this figure129Total liabilities, Q1 FY2025, at 2025-03-31$128.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure133Total liabilities, Q2 FY2025, at 2025-06-30$133.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure134Total liabilities, Q3 FY2025, at 2025-09-30$133.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure140Total liabilities, FY2025, at 2025-12-31$140.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure140Total liabilities, Q1 FY2026, at 2026-03-31$139.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure144Total liabilities, Q2 FY2026, at 2026-06-30$144.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Long-term debt$m99.1Long-term debt, Q3 FY2023, at 2023-09-30$99.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-14, accession 0001558370-23-018917.Report this figure101Long-term debt, FY2023, at 2023-12-31$100.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-28, accession 0001558370-25-003985.Report this figure102Long-term debt, Q1 FY2024, at 2024-03-31$101.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-09, accession 0001558370-24-007481.Report this figure103Long-term debt, Q2 FY2024, at 2024-06-30$103.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-06, accession 0001558370-24-010967.Report this figure104Long-term debt, Q3 FY2024, at 2024-09-30$104.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figure103Long-term debt, FY2024, at 2024-12-31$102.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-27, accession 0001104659-26-036214.Report this figure99.9Long-term debt, Q1 FY2025, at 2025-03-31$99.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure97.5Long-term debt, Q2 FY2025, at 2025-06-30$97.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure92.3Long-term debt, Q3 FY2025, at 2025-09-30$92.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure84.7Long-term debt, FY2025, at 2025-12-31$84.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure77.9Long-term debt, Q1 FY2026, at 2026-03-31$77.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure0.0Long-term debt, Q2 FY2026, at 2026-06-30$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reported0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2026-03-27, accession 0001104659-26-036214.Report this figure5.6Current portion of debt, Q1 FY2025, at 2025-03-31$5.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure11.2Current portion of debt, Q2 FY2025, at 2025-06-30$11.2m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure16.8Current portion of debt, Q3 FY2025, at 2025-09-30$16.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure24.9Current portion of debt, FY2025, at 2025-12-31$24.9m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure22.4Current portion of debt, Q1 FY2026, at 2026-03-31$22.4m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure104Current portion of debt, Q2 FY2026, at 2026-06-30$104.5m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure
Shareholders' equity$m(40.6)Shareholders' equity, Q3 FY2023, at 2023-09-30−$40.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figure(56.5)Shareholders' equity, FY2023, at 2023-12-31−$56.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-27, accession 0001104659-26-036214.Report this figure(72.4)Shareholders' equity, Q1 FY2024, at 2024-03-31−$72.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure(74.3)Shareholders' equity, Q2 FY2024, at 2024-06-30−$74.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure(85.6)Shareholders' equity, Q3 FY2024, at 2024-09-30−$85.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure(93.1)Shareholders' equity, FY2024, at 2024-12-31−$93.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure(90.2)Shareholders' equity, Q1 FY2025, at 2025-03-31−$90.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure(108)Shareholders' equity, Q2 FY2025, at 2025-06-30−$107.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure(88.9)Shareholders' equity, Q3 FY2025, at 2025-09-30−$88.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure(95.5)Shareholders' equity, FY2025, at 2025-12-31−$95.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure(106)Shareholders' equity, Q1 FY2026, at 2026-03-31−$105.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure(115)Shareholders' equity, Q2 FY2026, at 2026-06-30−$115.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure

Cash flow

Operating cash flow−$6.1m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
BioXcel Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(37.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$37.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001558370-24-015629. Derived: 9-month figure less the 6-month figure.Report this figure(26.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$26.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-28, accession 0001558370-25-003985. Derived: 12-month figure less the 9-month figure.Report this figure(17.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$17.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure(23.2)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$23.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001558370-25-011158. Derived: 6-month figure less the 3-month figure.Report this figure(16.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$16.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001104659-25-109880. Derived: 9-month figure less the 6-month figure.Report this figure(14.8)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure(12.0)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$12.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure(12.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$12.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001104659-26-095965. Derived: 6-month figure less the 3-month figure.Report this figure(18.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$18.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001104659-25-109880. Derived: 9-month figure less the 6-month figure.Report this figure(14.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$14.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure(11.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$11.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure(6.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$6.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001104659-26-095965. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001558370-24-015629. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-28, accession 0001558370-25-003985. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001104659-25-109880. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001104659-26-095965. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001104659-25-109880. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-27, accession 0001104659-26-036214. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001104659-26-095965. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)30.30m, Q2 FY2026
BioXcel Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares28.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3028,022,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001558370-23-018917.Report this figure28.6Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3128,616,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001558370-24-007481.Report this figure29.2Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3029,187,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001558370-24-010967.Report this figure29.3Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3029,268,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001558370-24-015629.Report this figure1.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-311,929,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001558370-25-007269.Report this figure2.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-302,516,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001558370-25-011158.Report this figure2.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-302,649,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure4.8Diluted shares (weighted), Q1 FY2025, three months to 2025-03-314,834,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure7.8Diluted shares (weighted), Q2 FY2025, three months to 2025-06-307,843,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure14.2Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3014,196,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001104659-25-109880.Report this figure23.6Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3123,571,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-15, accession 0001104659-26-061769.Report this figure30.3Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3030,300,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure

Shares outstanding: 31.31mShares outstanding, period not labelled, at 2026-08-1131,305,499 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001104659-26-095965.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.